4164
承業醫
0.00 (0.00%)25.40267成交張數21.71本益比0.66股價淨值比4.37%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入
營業收入20254,398年增 +22.2%
毛利率202526.1%最新一期
營業利益率20259.0%最新一期
每股盈餘20251.00年增 -1.0%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 營業成本合計 | 71.9% | 67.5% | 70.9% | 72.7% | 67.5% | 65.2% | 69.7% | 72.4% | 78.9% | 73.9% | |
| 營業毛利（毛損） | 28.1% | 32.5% | 29.1% | 27.3% | 32.5% | 34.8% | 30.3% | 27.6% | 21.1% | 26.1% | |
| 營業毛利（毛損）淨額 | 28.1% | 32.5% | 29.1% | 27.3% | 32.5% | 34.8% | 30.3% | 27.6% | 21.1% | 26.1% | |
| 推銷費用 | 6.2% | 5.4% | 5.0% | 4.2% | 4.6% | 5.0% | 6.2% | 5.6% | 7.5% | 11.0% | |
| 管理費用 | 7.9% | 10.5% | 7.7% | 5.6% | 7.5% | 9.6% | 8.0% | 6.1% | 7.0% | 5.8% | |
| 預期信用減損損失（利益） | – | – | -1.9% | -0.6% | 0.0% | 0.0% | 0.1% | 0.0% | -0.1% | 0.3% | |
| 營業費用合計 | 14.1% | 15.9% | 10.8% | 9.4% | 12.4% | 14.6% | 14.3% | 11.7% | 14.5% | 17.1% | |
| 營業利益（損失） | 14.0% | 16.7% | 18.3% | 18.0% | 20.1% | 20.2% | 16.0% | 15.8% | 6.6% | 9.0% | |
| 利息收入 | – | – | – | – | 0.5% | 0.4% | 0.4% | 0.5% | 0.7% | 0.5% | |
| 其他收入 | 0.3% | 1.1% | 0.6% | 1.1% | 0.4% | 0.4% | 0.4% | 0.2% | 1.5% | 0.5% | |
| 其他利益及損失淨額 | -0.7% | -15.2% | -0.8% | -0.2% | 0.3% | 1.3% | 1.8% | 0.1% | 0.1% | -0.1% | |
| 財務成本淨額 | 3.1% | 3.4% | 3.3% | 2.7% | 3.1% | 2.6% | 2.4% | 2.3% | 2.7% | 2.6% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | -0.1% | -0.4% | -0.2% | -0.1% | -0.0% | 0.4% | -0.0% | 0.0% | 0.0% | -0.1% | |
| 營業外收入及支出合計 | -3.6% | -17.9% | -3.7% | -1.8% | -1.9% | -0.1% | 0.3% | -1.4% | -0.4% | -1.9% | |
| 稅前淨利（淨損） | 10.3% | -1.2% | 14.7% | 16.2% | 18.2% | 20.1% | 16.3% | 14.4% | 6.2% | 7.1% | |
| 所得稅費用（利益）合計 | 3.0% | 3.0% | 2.0% | 2.9% | 4.0% | 4.5% | 3.2% | 3.5% | 1.1% | 2.0% | |
| 繼續營業單位本期淨利（淨損） | 7.3% | -4.2% | 12.7% | 13.2% | 14.2% | 15.6% | 13.1% | 11.0% | 5.1% | 5.1% | |
| 本期淨利（淨損） | 7.3% | -4.2% | 12.7% | 13.2% | 14.2% | 15.6% | 13.1% | 11.0% | 5.1% | 5.1% | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | -1.7% | -0.3% | -0.1% | -0.2% | -0.1% | 0.2% | 0.1% | -0.4% | |
| 不重分類至損益之項目： | – | – | – | -0.3% | -0.1% | -0.2% | -0.1% | 0.2% | 0.1% | -0.4% | |
| 國外營運機構財務報表換算之兌換差額 | -1.2% | -0.4% | -0.3% | -0.5% | 0.2% | -0.2% | 0.3% | -0.1% | 0.4% | -0.1% | |
| 與可能重分類之項目相關之所得稅 | 0.4% | -0.1% | 0.1% | 0.0% | -0.0% | 0.0% | 0.0% | 0.0% | -0.0% | 0.0% | |
| 後續可能重分類至損益之項目： | – | – | – | -0.5% | 0.2% | -0.2% | 0.3% | -0.1% | 0.4% | -0.1% | |
| 其他綜合損益（淨額） | -3.6% | 6.6% | -2.1% | -0.8% | 0.1% | -0.4% | 0.3% | 0.0% | 0.5% | -0.4% | |
| 本期綜合損益總額 | 3.7% | 2.3% | 10.6% | 12.4% | 14.3% | 15.2% | 13.3% | 11.0% | 5.6% | 4.7% | |
| 母公司業主（淨利∕損） | 7.2% | -4.1% | 12.9% | 13.4% | 14.3% | 15.6% | 12.0% | 10.8% | 4.7% | 4.2% | |
| 非控制權益（淨利∕損） | 0.1% | -0.1% | -0.2% | -0.2% | -0.1% | -0.1% | 1.1% | 0.2% | 0.4% | 0.9% | |
| 母公司業主（綜合損益） | 3.6% | 2.5% | 10.8% | 12.6% | 14.4% | 15.3% | 12.3% | 10.8% | 5.2% | 3.8% | |
| 非控制權益（綜合損益） | 0.1% | -0.1% | -0.2% | -0.2% | -0.1% | -0.1% | 1.1% | 0.2% | 0.4% | 0.9% | |
| 基本每股盈餘 | 0.1% | -0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | |
| 繼續營業單位淨利（淨損） | 0.0% | -0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 稀釋每股盈餘 | 0.1% | -0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | |
| 研究發展費用 | – | – | 0.0% | 0.2% | 0.2% | 0.0% | – | – | – | – | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | – | – | – | 0.0% | 0.0% | – | – | – | – | – | |
| 備供出售金融資產未實現評價損益 | -1.9% | 6.9% | 0.0% | – | – | – | – | – | – | – | |
| 採用權益法認列關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | 0.0% | -0.0% | 0.0% | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。